ACT CAPITAL MANAGEMENT, LLC

Fundamental concentrated ★Signal healthcare specialist (62%) CIK 1442273
League rank
#433
in Fundamental concentrated · #1255 overall
Long book
$127.2M
Q1 2026
Positions
56
Top-10 weight
74%
concentration
Last quarter
+16.0%
SPY +14.8%
Turnover
54%
of book per quarter

Strategy in plain words

auto-generated from filings

ACT CAPITAL MANAGEMENT, LLC is a concentrated fundamental stock-picker, specialised in healthcare (62% of the long book), running a $127.2M US long book across 56 positions.

The portfolio is concentrated: the top 10 names carry 74% of the portfolio. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: KRYSTAL BIOTECH INC, CHEVRON CORP, EXXON MOBIL CORP, CELCUITY INC, TG THERAPEUTICS INC.

We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q4 2025
+5.2%
Q1 2026
+16.0%

Sector allocation

Healthcare
59%
Energy
24%
Consumer discretionary
6%
Technology
5%
Materials
2%
Utilities
2%
Industrials
1%
Financials
0%

Long book by quarter

$123.7M
Q4 2025
$127.2M
Q1 2026

What does ACT CAPITAL own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
KRYS KRYSTAL BIOTECH INCHealthcare60.5K$15.6M12.3%0.0%
CVX CHEVRON CORPEnergy75.0K$15.5M12.2%-4.5%
XOM EXXON MOBIL CORPEnergy70.0K$11.9M9.3%-15.2%
CELC CELCUITY INCHealthcare91.7K$10.5M8.2%+44.6%
TGTX TG THERAPEUTICS INCHealthcare249.0K$8.3M6.5%-7.4%
AMZN AMAZON.COM INCConsumer discretionary33.0K$6.9M5.4%+34.1%
VKTX VIKING THERAPEUTICS INCHealthcare209.3K$6.8M5.4%+1.6%
ARWR ARROWHEAD PHARMACEUTICALS INHealthcare82.5K$5.2M4.1%+10.0%
NKTR NEKTAR THERAPEUTICSHealthcare70.9K$5.1M4.0%+38.5%
CYTK CYTOKINETICS INCHealthcare64.5K$4.3M3.3%Held
ALMS ALUMIS INCHealthcare174.3K$3.8M3.0%New
ET ENERGY TRANSFER LPUtilities133.1K$2.6M2.0%Held
FCX FREEPORT-MCMORAN INCMaterials38.5K$2.3M1.8%New
AAOI APPLIED OPTOELECTRONICS INCTechnology25.9K$2.2M1.7%New
XENE XENON PHARMACEUTICALS INCHealthcare33.5K$1.9M1.5%New
NUVB NUVATION BIO INCHealthcare290.0K$1.2M1.0%-52.5%
STAA STAAR SURGICAL COHealthcare55.5K$1.0M0.8%Held
PRAX PRAXIS PRECISION MEDICINES IHealthcare2.7K$870K0.7%+285.7%
S SENTINELONE INC -CLASS ATechnology54.3K$699K0.5%New
LITE LUMENTUM HOLDINGS INCTechnology900$632K0.5%New
BE BLOOM ENERGY CORP- AIndustrials4.5K$610K0.5%-65.4%
CRGY CRESCENT ENERGY INC-AEnergy45.0K$608K0.5%-26.6%
KURA KURA ONCOLOGY INCHealthcare73.9K$601K0.5%Held
VIR VIR BIOTECHNOLOGY INCHealthcare64.3K$576K0.5%New
CRCL CIRCLE INTERNET GROUP INCFinancials6.0K$572K0.4%New
HCC WARRIOR MET COAL INCMaterials6.0K$559K0.4%-50.0%
PATH UIPATH INC - CLASS ATechnology50.0K$555K0.4%+6.4%
SRRK SCHOLAR ROCK HOLDING CORPHealthcare10.8K$531K0.4%-10.0%
WGS GENEDX HOLDINGS CORPHealthcare8.0K$514K0.4%+166.7%
MU MICRON TECHNOLOGY INCTechnology1.5K$507K0.4%New
NVDA NVIDIA CORPTechnology2.8K$488K0.4%New
REPL REPLIMUNE GROUP INCHealthcare61.5K$470K0.4%Held
RGNX REGENXBIO INCHealthcare56.0K$469K0.4%-32.1%
PALI PALISADE BIO INCHealthcare257.5K$451K0.4%+71.7%
OLMA OLEMA PHARMACEUTICALS INCHealthcare25.0K$373K0.3%-53.3%
GLUE MONTE ROSA THERAPEUTICS INCHealthcare22.5K$370K0.3%New
ONDS ONDAS INCTechnology37.5K$339K0.3%New
ACOG ALPHA COGNITION INCHealthcare51.5K$283K0.2%Held
MBX MBX BIOSCIENCES INCHealthcare9.0K$269K0.2%New
APC ARKO PETROLEUM CORPConsumer discretionary15.0K$268K0.2%New
KYTX KYVERNA THERAPEUTICS INCHealthcare30.0K$259K0.2%+19.5%
RYZ RYERSON HOLDING CORPConsumer discretionary10.8K$243K0.2%New
NKLR TERRA INNOVATUM GLOBAL NVIndustrials45.0K$209K0.2%Held
INCY INCYTE CORPHealthcare2.0K$188K0.1%New
CAPR CAPRICOR THERAPEUTICS INCHealthcare5.0K$152K0.1%+233.3%
VPG VISHAY PRECISION GROUPTechnology3.0K$130K0.1%New
ESPR ESPERION THERAPEUTICS INCHealthcare47.5K$130K0.1%Held
AMLX AMYLYX PHARMACEUTICALS INCHealthcare9.0K$125K0.1%Held
LSPD LIGHTSPEED COMMERCE INCTechnology12.5K$112K0.1%Held
LTRX LANTRONIX INCTechnology15.0K$79K0.1%New

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 8, 202656$127.2M canonicalSEC ↗
Q4 202513F-HRFeb 17, 202659$123.7M canonicalSEC ↗